OCR Improving the health, welfare and prosperity of the global community. $ 873 m venture capital investment (in the last 5 years ) 48 venture-backed companies spun out (in the last 5 years ) 1367 active patents worldwide (as of 2020) 4th IPO (4 years straight ) 38 SRA/CRAs resulting in $17M in NEW FUNDING (in 2020) Have an Idea? Talk to OCR Faculty Industry Students OCR Programs The Fund seeks to support innovative, investigator-initiated research The Summit brings together innovators, industry & venture investment firms. Where the top biotech opportunities within Yale take the stage to present to industry Helping women extend the impact of their scientific research into the real world. Programs and resources to guide Yale faculty & grad students in entrepreneurial pursuits OCR Events All Events OCR News The Blavatnik Fellowship in Life Science Entrepreneurship 2021/22 Cohort Three Fellows Join Yale’s Office of Cooperative Research (OCR) The Blavatnik Fellowship at Yale Read story Next Story Blavatnik-Funded Technology from Yale Secures $40M Investment In May 2020, Professor Peter Glazer was named a Blavatnik Fund for Innovation at Yale award Read story Next Story Kristin King, Angel Investor and Yale University Entrepreneur-In-Residence Spotlighted Kristin King, Angel Investor and Yale University Entrepreneur-In-Residence Spotlighted A Yale Read story Next Story Osmol Therapeutics Initiates IND Enabling Studies to Develop First Therapy for Prevention of Chemotherapy-Induced Peripheral Neuropathy -- Founded by Barbara Ehrlich, Ph.D. at Yale University -- Bob Linke appointed Chief Executive Read story Next Story All News
The Blavatnik Fellowship in Life Science Entrepreneurship 2021/22 Cohort Three Fellows Join Yale’s Office of Cooperative Research (OCR) The Blavatnik Fellowship at Yale Read story Next Story
Blavatnik-Funded Technology from Yale Secures $40M Investment In May 2020, Professor Peter Glazer was named a Blavatnik Fund for Innovation at Yale award Read story Next Story
Kristin King, Angel Investor and Yale University Entrepreneur-In-Residence Spotlighted Kristin King, Angel Investor and Yale University Entrepreneur-In-Residence Spotlighted A Yale Read story Next Story
Osmol Therapeutics Initiates IND Enabling Studies to Develop First Therapy for Prevention of Chemotherapy-Induced Peripheral Neuropathy -- Founded by Barbara Ehrlich, Ph.D. at Yale University -- Bob Linke appointed Chief Executive Read story Next Story
